Medicines Optimisation Tony Jamieson Clinical Lead for Medicines
- Slides: 11
Medicines Optimisation Tony Jamieson Clinical Lead for Medicines 13/07/2015
Our Aim Harness the energy, talent and enthusiasm of people to deliver lasting improvements in patient and population health by leading the adoption of Medicines Optimisation principles across the health and care system.
Our Strategy Work in partnership to reduce the variation in medicines optimisation by fostering the adoption of excellence.
A New Perspective Medicines Optimisation Principles (Royal Pharmaceutical Society 2013)
Our approach Y&H AHSN Medicines Optimisation: • • • Reduce Variation Adoption of Innovation Drive for excellence Delivering at scale Patient Safety Collaborative Human Factors in Medicines Safety
Our Partners Academic Institutions NHS Commissioners Strategic Clinical Network NHS Providers Pharmaceutical Industry and services Providers of support services
Our Tactics Human Factors Communities of Practice Exemplars Behaviour Change Inspiring Research The Patient’s Experience Positive Deviance Health economics
Exemplars Stroke prevention in Atrial Fibrillation Avoiding Hypoglycaemia in Diabetes Polypharmacy and Healthy Aging Asthma Antipsychotics
Our Projects
Medicines Safety – Impact Making Dispensing Safer Dispensing medicines has become safer in 8 community teams, building on established high performance to further protect patients from medication errors. We have demonstrated this improvement in our innovative Training and Action in Patient Safety (Ta. PS) programme for pharmacies and GP dispensaries.
Our Contact Details Y&H AHSN Improvement Academy www. yhahsn. org. uk www. improvementacademy. org @AHSN_Yand. H @Improve_academy @Pharm. Safe academy@yhahsn. nhs. uk
